LI OU. TNFRSF1B-DRIVEN MYELOID PLASTICITY CONSTITUTES A CLINICALLY TRACTABLE IMMUNOSUPPRESSIVE AXIS ACROSS HUMAN CANCERS. LIFE: International Journal of Health and Life-Sciences, [S. l.], p. 65–66, 2025. DOI: 10.20319/icrlsh.2025.6566. Disponível em: https://grdspublishing.org/index.php/life/article/view/2961. Acesso em: 5 dec. 2025.